Comparison of Brand versus Generic Antiepileptic Drug Adverse Event Reporting Rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)

OBJECTIVE: Despite the cost saving role of generic anti-epileptic drugs (AEDs), debate exists as to whether generic substitution of branded AEDs may lead to therapeutic failure and increased toxicity. This study compared adverse event (AE) reporting rates for brand vs. authorized generic (AG) vs. ge...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Epilepsy Res
Main Authors: Rahman, Md. Motiur, Alatawi, Yasser, Cheng, Ning, Qian, Jingjing, Plotkina, Annya V., Peissig, Peggy L., Berg, Richard L., Page, David, Hansen, Richard A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5842137/
https://ncbi.nlm.nih.gov/pubmed/28641219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eplepsyres.2017.06.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados